TL;DR
This study investigated the relationship between enlarged perivascular spaces (ePVS) and cerebral small vessel disease (SVD) markers in two distinct Asian cohorts. While ePVS were generally not associated with SVD severity or location in a memory clinic group, the population-based group showed that more severe SVD (lacunes, microbleeds, and white matter hyperintensities) was linked to ePVS in the basal ganglia.
What Problem Does This Paper Address?
Cerebral small vessel disease (SVD) is a major contributor to cognitive decline and dementia in the elderly. SVD encompasses various brain abnormalities visible on MRI, such as white matter hyperintensities (WMH), lacunes, and cerebral microbleeds (CMBs). Enlarged perivascular spaces (ePVS), which are fluid-filled spaces around blood vessels, are also common in aging brains and are often found alongside SVD. However, the precise relationship between the location and severity of different SVD markers and ePVS, particularly in different clinical settings (e.g., memory clinics vs. general population), remains unclear. This study aims to clarify these associations by examining data from both a memory clinic cohort and a population-based cohort.
Methods
The researchers utilized data from two Singaporean studies: a memory clinic-based case-control study and the population-based Epidemiology of Dementia in Singapore (EDIS) study. Participants in both groups underwent comprehensive medical and neuropsychological assessments, along with brain MRI scans.
Key SVD markers were quantified:
- Cerebral Microbleeds (CMBs) and Lacunes were categorized by location (strictly lobar, strictly deep, or mixed) and severity (0, 1, or ≥2).
- White Matter Hyperintensities (WMH) volume was automatically segmented and classified into anterior and posterior distributions, with total WMH volume categorized into tertiles to represent severity.
- Enlarged Perivascular Spaces (ePVS) were visually counted in specific brain regions: centrum semiovale and basal ganglia.
Statistical analysis involved negative binomial regression models to assess the association between SVD markers and ePVS counts, reporting rate ratios (RR) and 95% confidence intervals (CI). Models were adjusted for age, gender, and vascular risk factors (hypertension, hyperlipidemia, diabetes). A Bonferroni correction was applied for multiple testing.
Datasets
- Memory Clinic Cohort: 375 participants (median age 73 years) recruited from memory clinics at the National University Hospital (August 2010 - December 2016).
- Epidemiology of Dementia in Singapore (EDIS) Study: 583 participants (median age 70 years) from a large population-based study. This analysis was restricted to Chinese and Malay participants due to data availability.
Key Insights and Ideas
- ePVS are not universally linked to SVD severity: The study found that increased severity of SVD markers (CMBs, lacunes, WMH) was not associated with the total count of ePVS in the memory clinic group. This suggests that ePVS might not simply be a direct consequence of overall SVD burden in this specific clinical setting.
- Location matters, but only in the general population: While location-specific SVD analysis didn't reveal strong associations in the memory clinic group, the EDIS population-based study showed a significant link between SVD severity and ePVS specifically in the basal ganglia. This highlights how clinical context can influence the observed relationships.
- Basal ganglia ePVS as a potential indicator: The finding that more lacunes, microbleeds, and higher WMH volume were associated with basal ganglia ePVS in the EDIS group suggests that ePVS in this particular location might serve as a more sensitive marker for SVD in a general population context, independent of common risk factors.
- Potential for ePVS as an early SVD marker: The authors speculate that ePVS might be an early marker of SVD, potentially appearing before more established lesions, especially in younger or less affected individuals.
Key Results
- Memory Clinic Cohort: No significant association was found between the severity or location of SVD markers (CMBs, lacunes, WMH) and total, centrum semiovale, or basal ganglia ePVS counts.
- EDIS Population-Based Cohort:
- Presence of ≥2 lacunes was associated with basal ganglia ePVS (RR = 1.61, p = 0.009).
- Presence of ≥2 CMBs was associated with basal ganglia ePVS (RR = 1.40, p = 0.012).
- Higher WMH volume (third tertile) was associated with basal ganglia ePVS (RR = 1.41, p = 0.006).
- These associations were independent of age, gender, and vascular risk factors.
- Secondary Analysis (Cognitively Impaired EDIS group): Similar associations between SVD severity and basal ganglia ePVS were observed.
- Secondary Analysis (NCI EDIS group): Interestingly, increased strictly lobar lacunes and higher WMH volume were associated with lower centrum semiovale ePVS counts, possibly due to misclassification or obscuring effects on MRI.
Limitations and Future Work
- Cross-sectional design: The study cannot establish causality or the chronological order of SVD development and ePVS.
- Potential for residual confounding: Despite adjusting for several risk factors, other unmeasured factors might still influence the results.
- Single-slice grading: ePVS were graded on specific slices, potentially missing some lesions.
- Generalizability: The study was conducted in an Asian population, limiting generalizability to other ethnicities.
- ePVS size: The study primarily focused on ePVS ≥1 mm and could not analyze the association for larger ePVS (≥3 mm) due to small sample size.
The authors suggest further research in larger cohorts using consistent and harmonized methods for ePVS grading to better understand the underlying mechanisms of SVD and their role in cognitive decline. They also propose exploring the potential of ePVS as an early SVD marker.
Summary updated